Methylobacterium zatmanii Green et al. (ATCC® 700809)

Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Isolation
Blood - human
isolation date: 1997
Type Strain no
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Antibiotic Resistance
Resistant to ceftazidime
Resistant to ciprofloxacin
Resistant to co-trimoxazole
Sensitive to amikacin
Sensitive to ceftriaxone
Sensitive to imipenem
Sensitive to piperacillin
Medium ATCC® Medium 1099: CYE (Charcoal Yeast Extract) Buffered Medium
Growth Conditions
Temperature: 37.0°C
Atmosphere: 5% CO2
Name of Depositor B Hornei
Special Collection NCRR Contract
Isolation
Blood - human
isolation date: 1997
Year of Origin 1997
References

Hornei B, et al. Systemic infection of an immunocompromised patient with Methylobacterium zatmanii. J. Clin. Microbiol. 37: 248-250, 1999. PubMed: 9854105

blood from a 60-year-old male patient with acute myeloid leukemia and agranulocytosis who had undergone 5 months of chemotherapy

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation